Navigation Links
Gene activity in the brain depends on genetic background
Date:10/19/2010

SEATTLE, Wash.October 18, 2010Researchers at the Allen Institute for Brain Science have found that the same genes have different activity patterns in the brain in individuals with different genetic backgrounds. These findings may help to explain individual differences in the effectiveness and side-effect profiles of therapeutic drugs and thus have implications for personalized medicine. The study is available in this week's online early edition of the Proceedings of the National Academy of Sciences (www.pnas.org).

In this study, the authors compared where in the brain each of 49 different pharmaceutically related genes is expressed, or turned on, in seven genetically distinct groups of mice with known genealogical relationships. By analyzing 203 distinct brain areas over 15,000 thin sections of tissue, they precisely mapped where these genes are active, down to the level of individual cells. The genes all encode molecular targets of well-known pharmaceuticals, such as antidepressants, antipsychotics and pain relievers including Prozac, Imitrex, and Aricept.

More than half of the genes examined showed striking, localized differences in expression patterns between the different genetic groups, or strains, of mice. For example, the dopamine D2 receptor genewhich encodes a target of action of Zyprexa, a drug used for schizophrenia and bipolar disorderis active in a memory-related area called the entorhinal cortex in one strain of mice, but not in two others. Because different parts of the brain have different functions, variations in the localization of gene activity likely have functional implications.

"It is clear that to understand how genes translate to behavioral and other differences between individuals and species, we need to look beyond just the inherited sequences of the genes themselves," said Allan Jones, chief executive officer of the Allen Institute for Brain Science. "Our results show that genetic backgroundthe specific blend of gene variants comprising an individual genomecan influence how the activity of a given gene is regulated and where it is expressed."

Taken all together, the data from the study demonstrate that closer genetic relatives exhibit fewer differences in gene expression patterns, whereas more distant relatives show greater variation. Interestingly, the researchers found that the expression variations between genetic strains were more likely to be found in areas of the brain that evolved more recently. These regions are most commonly linked to higher order functions such as cognition, social behavior, learning and memory.

"This study shows how large-scale datasets can be used to reveal fundamental biological patterns that would likely be missed otherwise," said Jones. "It is likely that many important differences between individuals and species may result from combinations of many small but clear differences in gene expression."

Jones added, "Our ongoing Allen Human Brain Atlas project, which will provide gene expression data across the brains of multiple donors, will help researchers translate these results from an animal model to a human system."


'/>"/>

Contact: Aaron Blank
aaronblank@feareygroup.com
206-343-1543
Allen Institute for Brain Science
Source:Eurekalert

Related medicine news :

1. Resting brain activity associated with spontaneous fibromyalgia pain
2. Children have a negative impact on physical activity among individuals with heart disease
3. Concordia researcher leads study that finds kids reduce physical activity for heart patients
4. Inactivity no contributor to childhood obesity epidemic
5. Teenage physical activity reduces risk of cognitive impairment in later life
6. Abnormal brain activity in migraineurs is not restricted to attacks
7. Targeting disease remission has socio-economic benefits over low disease activity
8. Onrec Predicts Significant Recruiting Activity this Fall
9. BRAF inhibitor shows promising preclinical activity against melanoma
10. Study: Adults take their physical activity on the road
11. Non-intense physical activity to reduce depression and boost recovery of stroke patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/20/2017)... ... July 20, 2017 , ... ... Business Architecture Body of Knowledge (BIZBOK® Guide )v 6.0 is now available for ... this effort through Guild collaborative teams. , Non-members may download the Part ...
(Date:7/20/2017)... ... July 20, 2017 , ... LINET, an international leader ... to their product line: the AVE 2 birthing bed. , Perfectly suitable for labor, ... new level of comfort and efficiency to every phase of childbirth. The AVE 2 ...
(Date:7/20/2017)... TX (PRWEB) , ... July 19, 2017 , ... At ... the availability of temporomandibular joint (TMJ) treatment and dental implants in Waco, ... TRIOS® intraoral scanner and the T-Scan™ by Tekscan®, they can capture details in the ...
(Date:7/20/2017)... ... July 19, 2017 , ... Adolfson ... healthcare project manager, Josh Christensen. As a leader in healthcare construction, AP has ... its healthcare resume in the Midwest with Josh now on board. , ...
(Date:7/20/2017)... ... ... a fun-filled, action-packed memoir of adventures. “Fidget” is the creation of published author, Carol ... summa cum laude graduate of Gardner Webb University. She has won numerous awards during ... public school, Lynn continued to pursue her love for music through playing piano, harp, ...
Breaking Medicine News(10 mins):
(Date:7/11/2017)... 2017 Oramed Pharmaceuticals Inc. (NASDAQ: ... focused on the development of oral drug delivery systems, ... (FDA) has agreed to schedule an End-of-Phase II meeting ... of its oral insulin capsule ORMD-0801 in the treatment ... primary and secondary endpoints by indicating a statistically significant ...
(Date:7/10/2017)... July 10, 2017  The tenth annual BioPharm ... MA at the Sheraton Boston Hotel, September ... access to global decision makers and innovative biotech startup ... science leaders during two impactful days. BioPharm America is ... with additional networking opportunities with 4,500+ life science industry ...
(Date:7/5/2017)... Oramed Pharmaceuticals Inc. (NASDAQ: ... clinical-stage pharmaceutical company focused on the development of oral drug ... the Israel Securities Authority to dual-list its common stock on ... commence trading on the TASE on July 12, 2017 under ... the Company, it is expected that Oramed will be included ...
Breaking Medicine Technology: